News | May 22, 2026
OncoSil secures TGA approval for pancreatic cancer device
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Subscribe To Our Newsletter & Stay Updated
